Elevated CK‐MB after ICI treatment independently contributes to the risk of developing ICI‐associated myocarditis, whereas higher cTnI and NLR after ICI treatment serve as independent risk factors for the progression to severe ICI‐associated myocarditis. Here, TNNI3 is linked to myocarditis.